Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
about
Essential thrombocythemiaRationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisClinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia.European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis.Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia.Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond.A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.Rethinking the diagnostic criteria of polycythemia vera.Myeloproliferative neoplasms: Morphology and clinical practice.European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360?5 - Reply.[Myeloproliferative neoplasms: histopathological and molecular pathological diagnosis].
P2860
Q21202968-DE1EB762-B699-4750-A2AB-15FF04433591Q26772881-7FD2B610-F66C-4F73-BCE7-FF66195D4B46Q33328618-427736C4-1F6A-44F4-A17A-B5D0509F04B0Q33837946-03EB72C3-F6B0-4B64-B2AE-260AA921C977Q33868344-8689E880-27EC-43B0-BAFF-3E4C2F04B1FEQ35794415-DEAF3F21-9F8A-47FF-9584-35A2F7D164C5Q36234490-C947D915-DA24-4686-A4B3-E621C5378861Q36270096-9C91E773-EEFA-4D02-8C0B-DA497F60179CQ36362041-3BBA879F-0510-469C-A775-0C8E1DC0E3CFQ36634607-D30F26D4-E235-407D-B841-19D788D14914Q37642058-F4452F07-81E3-4E86-80A6-2B0CFB22DBCCQ38172388-F8425D55-9070-47FB-8766-DE168ADCEA40Q38683559-7B1DA32E-8412-4589-94B3-30FA7D1839C9Q46804782-DD91319E-5F08-48CB-A3F9-F5F186B186D0Q48631037-4EE1C8EC-5F16-4847-8D49-96C6E5D9A35E
P2860
Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Classification and staging of ...... ogy from bone marrow biopsies.
@en
type
label
Classification and staging of ...... ogy from bone marrow biopsies.
@en
prefLabel
Classification and staging of ...... ogy from bone marrow biopsies.
@en
P2093
P2860
P1433
P1476
Classification and staging of ...... ogy from bone marrow biopsies.
@en
P2093
P2860
P356
10.3109/10428199609074357
P478
22 Suppl 1
P577
1996-09-01T00:00:00Z